Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Lactobacillus brevis SBC8803

What does the research say about Lactobacillus brevis SBC8803?

12 health outcomes synthesised

Lactobacillus brevis SBC8803 has been studied for 12 health outcomes, with the strongest research support for reducing fatigue (moderate evidence from 4 studies). Other areas, such as improved skin hydration, have low evidence but are researched in 10 studies, often using heat-killed cells at 25–50 mg/day. The research is predominantly preliminary, with many reviews and few primary trials.

Strongest evidence: The only outcome with moderate evidence strength is reduced fatigue, based on 4 studies (1 RCT, 3 reviews). The RCT (n=53) showed a statistically significant moderate improvement in exercise performance and fatigue markers over six weeks. No consistent dose was reported, but the effects were small to moderate. No other outcome reached moderate evidence.

Mixed or weaker evidence: All remaining outcomes have low or very low evidence. For example, improved skin hydration (10 studies, low evidence) showed small beneficial effects, but only one primary trial reached marginal significance. Improved skin barrier function (5 studies, low evidence), reduced body fat (4 studies, low evidence), and improved sleep quality (7 studies, very low evidence) all suffer from publication bias, lack of statistical significance, or reliance on secondary reviews. Outcomes like reduced alcohol-induced liver injury (3 studies, low evidence) are based only on animal and cell models.

Effective dose patterns: The only outcome with a reported effective dose is improved skin hydration: 25–50 mg/day of heat-killed postbiotic cells. No other outcomes had consistent dose data. The heat-killed form may not generalize to live probiotic products.

Population insights: Beneficial effects were observed in specific subgroups: improved skin hydration in adults with mild to moderate dry skin, especially middle-aged women; reduced body fat in obese individuals without comorbidities; improved skin health in healthy middle-aged and elderly; reduced inflammation in healthy adults and people with IBD; improved immune function in patients with psoriasis.

Notable caveats: Across all outcomes, the literature is subject to publication bias, and many studies did not reach statistical significance. The evidence base is dominated by review articles, with only a handful of primary trials. Several outcomes lack human data or directly test the specific strain SBC8803. The effective form (heat-killed vs. live) is unclear for most outcomes, and doses are rarely reported consistently.

Frequently asked

  • What is Lactobacillus brevis SBC8803 good for according to research?
    Research on Lactobacillus brevis SBC8803 suggests possible benefits for 12 health outcomes, with the strongest evidence for reducing fatigue (moderate evidence from 4 studies). Other promising but weaker evidence supports improved skin hydration, skin barrier function, and reduced body fat. Most research is preliminary and based on reviews or small studies.
  • What dose of Lactobacillus brevis SBC8803 is typically used in studies?
    Only one outcome, improved skin hydration, has a reported effective dose: 25–50 mg/day of heat-killed cells. For other outcomes, no consistent dose was reported across studies, and many studies did not specify dose or form.
  • Who benefits most from Lactobacillus brevis SBC8803?
    Beneficial effects are noted in specific populations: adults with dry skin (for hydration), especially middle-aged women; obese individuals without comorbidities (for body fat); healthy middle-aged and elderly (for skin health); healthy adults and people with IBD (for inflammation); and patients with psoriasis (for immune function). However, evidence is limited.
  • Are there caveats or limitations in the research on Lactobacillus brevis SBC8803?
    Yes. Most research is low quality, with publication bias, lack of statistical significance, and reliance on reviews rather than primary trials. Many studies use heat-killed cells, which may differ from live probiotics. Doses and study durations are often unreported, and some outcomes lack human data.
  • Does Lactobacillus brevis SBC8803 help with fatigue?
    Four studies, including one randomized controlled trial (n=53), report beneficial effects of Lactobacillus brevis SBC8803 on reducing fatigue, with small to moderate improvements. The RCT showed a statistically significant moderate benefit on exercise performance and fatigue markers after six weeks. Evidence strength is moderate.
  • Does Lactobacillus brevis SBC8803 improve skin hydration?
    Ten studies, all reporting beneficial effects, suggest Lactobacillus brevis SBC8803 may improve skin hydration, but the evidence strength is low. The studied dose is 25–50 mg/day of heat-killed cells, and effects were small. Only one study reached statistical significance, and most are secondary reviews.

  • Simple Slumbers

    By Unisom

    Out of Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    		Out
    iHerb
    $14.86
    		In
    Vitacost
    $-
    		Out
    Vitamin Shoppe
    $-
    		Out
Back to top